- Home
- MCRB vs EFSI Comparison
MCRB vs EFSI Comparison
Compare MCRB & EFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- EFSI
- Stock Information
- Founded
- MCRB 2010
- EFSI 1881
- Country
- MCRB United States
- EFSI United States
- Employees
- MCRB N/A
- EFSI N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- EFSI Major Banks
- Sector
- MCRB Health Care
- EFSI Finance
- Exchange
- MCRB Nasdaq
- EFSI Nasdaq
- Market Cap
- MCRB 141.9M
- EFSI 167.5M
- IPO Year
- MCRB 2015
- EFSI N/A
- Fundamental
- Price
- MCRB $0.80
- EFSI $32.75
- Analyst Decision
- MCRB Buy
- EFSI
- Analyst Count
- MCRB 4
- EFSI 0
- Target Price
- MCRB $5.63
- EFSI N/A
- AVG Volume (30 Days)
- MCRB 844.5K
- EFSI 10.2K
- Earning Date
- MCRB 03-04-2025
- EFSI 01-01-0001
- Dividend Yield
- MCRB N/A
- EFSI 3.79%
- EPS Growth
- MCRB N/A
- EFSI 62.68
- EPS
- MCRB N/A
- EFSI 4.32
- Revenue
- MCRB $126,325,000.00
- EFSI $70,233,000.00
- Revenue This Year
- MCRB N/A
- EFSI N/A
- Revenue Next Year
- MCRB N/A
- EFSI N/A
- P/E Ratio
- MCRB N/A
- EFSI $7.58
- Revenue Growth
- MCRB 12856.41
- EFSI 11.27
- 52 Week Low
- MCRB $0.54
- EFSI $27.02
- 52 Week High
- MCRB $1.53
- EFSI $36.93
- Technical
- Relative Strength Index (RSI)
- MCRB 46.38
- EFSI N/A
- Support Level
- MCRB $0.81
- EFSI N/A
- Resistance Level
- MCRB $0.84
- EFSI N/A
- Average True Range (ATR)
- MCRB 0.04
- EFSI 0.00
- MACD
- MCRB 0.00
- EFSI 0.00
- Stochastic Oscillator
- MCRB 45.58
- EFSI 0.00
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About EFSI Eagle Financial Services Inc Common Stock
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending, and Wealth Management. It generates a majority of its revenue from the Community Banking segment.